Survival in elderly glioblastoma patients treated with bevacizumab-based regimens in the United States

BACKGROUND: The efficacy of bevacizumab (BEV) in elderly patients with glioblastoma remains unclear. We evaluated the effect of BEV on survival in this patient population using the Survival, Epidemiology, and End Results (SEER)-Medicare database. METHODS: This retrospective, cohort study analyzed SE...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurooncol Pract
Main Authors: Davies, Jessica, Reyes-Rivera, Irmarie, Pattipaka, Thirupathi, Skirboll, Stephen, Ugiliweneza, Beatrice, Woo, Shiao, Boakye, Maxwell, Abrey, Lauren, Garcia, Josep, Burton, Eric
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6655482/
https://ncbi.nlm.nih.gov/pubmed/31385957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npy001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados